Skip to content

Real-world Multicenter Registry to Determine Management and Quality of Care of Patients With Type 2 Diabetes , Hypertension, Heart Failure and/or Chronic Kidney Diseases in China (iCaReMe China)

Real-world Multicenter Registry to Determine Management and Quality of Care of Patients With Type 2 Diabetes , Hypertension, Heart Failure and/or Chronic Kidney Diseases in China (iCaReMe China)

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300073764
Enrollment
Unknown
Registered
2023-07-20
Start date
2023-07-24
Completion date
Unknown
Last updated
2024-07-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diabetes, hypertension, heart failure, chronic kidney disease

Interventions

Diabetes:not applicable
hypertension (with chronic kidney disease) :not applicable
heart failure:not applicable
chronic kidney disease:not applicable

Sponsors

Peking University People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: 1. Male or female patients aged >= 18 years; 2. Diagnosed with T2D; and or hypertension (with chronic kidney disease); and or heart failure; and or chronic kidney disease; 3. Willing and able to provide written informed consent to participate in the study.

Exclusion criteria

Exclusion criteria: 1. Having a life-threatening comorbidity with life expectancy < 1 year; 2. Participating in an interventional trial requiring informed consent; 3. Presenting with T1D as a primary disease condition.

Design outcomes

Primary

MeasureTime frame
Clinical characteristics;Disease management patterns;Healthcare resource utilisation per year;Clinical outcomes;

Countries

China

Contacts

Public ContactLinong Ji

Peking University People's Hospital

jiln@bjmu.edu.cn+86 10 8832 4105

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 6, 2026